-
Something wrong with this record ?
Naringenin attenuates testicular damage, germ cell death and oxidative stress in streptozotocin induced diabetic rats: naringenin prevents diabetic rat testicular damage
Souvik Roy, Noorjaman Rahaman, Faiqa Ahmed, Satyajit Metya, Santanu Sannigrahi
Language English Country Czech Republic
NLK
Free Medical Journals
from 2003 to 2013
Freely Accessible Science Journals
from 2003 to 2013
ROAD: Directory of Open Access Scholarly Resources
from 2002
- MeSH
- Estrogen Antagonists administration & dosage pharmacology MeSH
- Apoptosis drug effects MeSH
- Diabetes Mellitus, Experimental * drug therapy blood MeSH
- Flavanones * administration & dosage pharmacology MeSH
- Immunohistochemistry MeSH
- Interleukin-1beta MeSH
- Sperm Motility drug effects MeSH
- Oxidative Stress drug effects MeSH
- Sperm Count statistics & numerical data MeSH
- Rats, Wistar MeSH
- Microscopy, Scanning Tunneling MeSH
- Statistics as Topic MeSH
- Case-Control Studies MeSH
- Testis * enzymology immunology pathology MeSH
- Testosterone blood MeSH
- Transforming Growth Factor beta1 MeSH
- Germ Cells drug effects MeSH
- Animals MeSH
- Check Tag
- Male MeSH
- Animals MeSH
The aim of this study was to investigate the protective effect of naringenin on oxidative stress, on proinflammatory cytokines like TGF-beta1, IL-1beta and on programmed cell death in the testicular damage resulting from streptozotocin (STZ) induced diabetes in rats. Diabetes was induced by a single intraperitoneal injection of STZ (50 mg/kg), and the rats were treated with naringenin (5 mg/kg and 10 mg/kg) administered once a day orally for 10 weeks, starting 3 days after the STZ injection. At the end of the study, all animals were sacrificed. Testis tissue and blood samples were collected for the assessment of sperm parameters, and for biochemical and histopathological analysis. Naringenin treatment significantly decreased the levels of elevated tissue TBARS (thio-barbituric acid) and increased the superoxide dismutase (SOD), catalase and glutathione peroxidase (GPx) enzyme activities in the testis tissues. The naringenin-treated rats in the diabetic group showed an improved histological appearance, sperm parameters, and serum testosterone levels, along with a decrement of terminal dUTP nick end-labeling (TUNEL) detected program cell death and a reduced over expression of TGF-beta1, IL-1beta in Sertoli cells and Leydig cells. These results suggest that naringenin is a food supplement potentially beneficial in reducing testicular damage in diabetic rats by decreasing the oxidative stress related to programmed cell death.
References provided by Crossref.org
Literatura
- 000
- 00000naa a2200000 a 4500
- 001
- bmc13032963
- 003
- CZ-PrNML
- 005
- 20131213104755.0
- 007
- ta
- 008
- 131012s2013 xr ad f 000 0eng||
- 009
- AR
- 024 7_
- $a 10.2478/v10136-012-0026-7 $2 doi
- 040 __
- $a ABA008 $d ABA008 $e AACR2 $b cze
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Roy, Souvik $u Department of Pharmaceutical Technology, NSHM Knowledge Campus, Kolkata, India
- 245 10
- $a Naringenin attenuates testicular damage, germ cell death and oxidative stress in streptozotocin induced diabetic rats: naringenin prevents diabetic rat testicular damage / $c Souvik Roy, Noorjaman Rahaman, Faiqa Ahmed, Satyajit Metya, Santanu Sannigrahi
- 504 __
- $a Literatura
- 520 9_
- $a The aim of this study was to investigate the protective effect of naringenin on oxidative stress, on proinflammatory cytokines like TGF-beta1, IL-1beta and on programmed cell death in the testicular damage resulting from streptozotocin (STZ) induced diabetes in rats. Diabetes was induced by a single intraperitoneal injection of STZ (50 mg/kg), and the rats were treated with naringenin (5 mg/kg and 10 mg/kg) administered once a day orally for 10 weeks, starting 3 days after the STZ injection. At the end of the study, all animals were sacrificed. Testis tissue and blood samples were collected for the assessment of sperm parameters, and for biochemical and histopathological analysis. Naringenin treatment significantly decreased the levels of elevated tissue TBARS (thio-barbituric acid) and increased the superoxide dismutase (SOD), catalase and glutathione peroxidase (GPx) enzyme activities in the testis tissues. The naringenin-treated rats in the diabetic group showed an improved histological appearance, sperm parameters, and serum testosterone levels, along with a decrement of terminal dUTP nick end-labeling (TUNEL) detected program cell death and a reduced over expression of TGF-beta1, IL-1beta in Sertoli cells and Leydig cells. These results suggest that naringenin is a food supplement potentially beneficial in reducing testicular damage in diabetic rats by decreasing the oxidative stress related to programmed cell death.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a potkani Wistar $7 D017208
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 12
- $a experimentální diabetes mellitus $x farmakoterapie $x krev $7 D003921
- 650 12
- $a flavanony $x aplikace a dávkování $x farmakologie $7 D044950
- 650 _2
- $a antagonisté estrogenu $x aplikace a dávkování $x farmakologie $7 D004965
- 650 _2
- $a studie případů a kontrol $7 D016022
- 650 _2
- $a oxidační stres $x účinky léků $7 D018384
- 650 12
- $a testis $x enzymologie $x imunologie $x patologie $7 D013737
- 650 _2
- $a apoptóza $x účinky léků $7 D017209
- 650 _2
- $a interleukin-1beta $7 D053583
- 650 _2
- $a transformující růstový faktor beta1 $7 D053773
- 650 _2
- $a testosteron $x krev $7 D013739
- 650 _2
- $a počet spermií $x statistika a číselné údaje $7 D013076
- 650 _2
- $a motilita spermií $x účinky léků $7 D013081
- 650 _2
- $a statistika jako téma $7 D013223
- 650 _2
- $a zárodečné buňky $x účinky léků $7 D005854
- 650 _2
- $a imunohistochemie $7 D007150
- 650 _2
- $a rastrovací tunelová mikroskopie $7 D016252
- 700 1_
- $a Rahaman, Noorjaman $u Department of Pharmaceutical Technology, NSHM Knowledge Campus, Kolkata, India
- 700 1_
- $a Ahmed, Faiqa $u Department of Pharmaceutical Technology, NSHM Knowledge Campus, Kolkata, India $7 gn_A_00002462
- 700 1_
- $a Metya, Satyajit $u Department of Pharmaceutical Technology, NSHM Knowledge Campus, Kolkata, India
- 700 1_
- $a Sannigrahi, Santanu $u Department of Pharmaceutical Technology, NSHM Knowledge Campus, Kolkata, India
- 773 0_
- $t Journal of applied biomedicine $x 1214-021X $g Roč. 11, č. 3 (2013), s. 195-208 $w MED00012667
- 856 41
- $u https://jab.zsf.jcu.cz/pdfs/jab/2013/03/08.pdf $y plný text volně přístupný
- 910 __
- $a ABA008 $b B 2301 $c 1249 $y 4 $z 0
- 990 __
- $a 20131012094746 $b ABA008
- 991 __
- $a 20131213105440 $b ABA008
- 999 __
- $a ok $b bmc $g 997136 $s 831415
- BAS __
- $a 3
- BMC __
- $a 2013 $b 11 $c 3 $d 195-208 $i 1214-021X $m Journal of Applied Biomedicine $n J. Appl. Biomed. (Čes. Budějovice Print) $x MED00012667
- LZP __
- $c NLK188 $d 20131213 $a NLK 2013-43/ip